|
Name |
Ocimene
|
Molecular Formula | C10H16 | |
IUPAC Name* |
3,7-dimethylocta-1,3,6-triene
|
|
SMILES |
CC(=CCC=C(C)C=C)C
|
|
InChI |
InChI=1S/C10H16/c1-5-10(4)8-6-7-9(2)3/h5,7-8H,1,6H2,2-4H3
|
|
InChIKey |
IHPKGUQCSIINRJ-UHFFFAOYSA-N
|
|
Synonyms |
beta-Ocimene; 13877-91-3; 3,7-Dimethylocta-1,3,6-triene; OCIMENE; CHEBI:10436; 1,3,6-Octatriene,3,7-dimethyl-; (Z)-EC-OCIMENE; DSSTox_CID_27051; DSSTox_RID_82069; DSSTox_GSID_47051; beta-Ocimene (>90per cent); CHEMBL3187449; DTXSID70274135; 3,7-Dimethyl-1,3,6-octatrien; Tox21_302304; AKOS024319240; NCGC00256046-01; FT-0605370; E77940; Q27108635
|
|
CAS | 13877-91-3 | |
PubChem CID | 18756 | |
ChEMBL ID | CHEMBL3187449 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 136.23 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 10 | QED Weighted: | 0.402 |
Caco-2 Permeability: | -4.434 | MDCK Permeability: | 0.00002160 |
Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.051 |
30% Bioavailability (F30%): | 0.075 |
Blood-Brain-Barrier Penetration (BBB): | 0.9 | Plasma Protein Binding (PPB): | 87.26% |
Volume Distribution (VD): | 4.122 | Fu: | 12.67% |
CYP1A2-inhibitor: | 0.738 | CYP1A2-substrate: | 0.488 |
CYP2C19-inhibitor: | 0.273 | CYP2C19-substrate: | 0.888 |
CYP2C9-inhibitor: | 0.055 | CYP2C9-substrate: | 0.825 |
CYP2D6-inhibitor: | 0.133 | CYP2D6-substrate: | 0.81 |
CYP3A4-inhibitor: | 0.052 | CYP3A4-substrate: | 0.275 |
Clearance (CL): | 14.171 | Half-life (T1/2): | 0.678 |
hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.948 |
Drug-inuced Liver Injury (DILI): | 0.029 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.043 | Maximum Recommended Daily Dose: | 0.368 |
Skin Sensitization: | 0.951 | Carcinogencity: | 0.736 |
Eye Corrosion: | 0.977 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.889 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001568 | 1.000 | D0M1PQ | 0.268 | ||||
ENC001664 | 0.610 | D0H6VY | 0.240 | ||||
ENC001566 | 0.500 | D05XQE | 0.229 | ||||
ENC002306 | 0.385 | D09XWD | 0.213 | ||||
ENC001434 | 0.375 | D0S7WX | 0.186 | ||||
ENC001718 | 0.368 | D03VFL | 0.182 | ||||
ENC001641 | 0.367 | D0F1GS | 0.162 | ||||
ENC000314 | 0.360 | D0Z4NI | 0.162 | ||||
ENC001649 | 0.356 | D0Q6DX | 0.161 | ||||
ENC001735 | 0.350 | D06BLQ | 0.157 |